Navigation Links
Colon Cancer Relapse Mainly Caused by Stem Cells

Scientists report that stem cells are primarily responsible for the relapse of colon cancer. Stem cells are totipotent cells that have the capacity to// grow into any tissue.

Earlier researches have shown that in spite of being treated with chemotherapy, some cancers always return . These include breast cancer, blood cancer and brain cancer.

John Dick of the University of Toronto told reporters that researchers were aware that stem cells were the cause for relapse in breast , blood and brain cancer and wanted to find out if a similar mechanism was at work with colon cancer as it is one of the leading causes of cancer death in many parts of the world.

"It's critically important because the reality is that despite the therapies that we have available today, still a great number of people who have colon cancer relapse, which means that our therapies are not completely effective," said John Dick.

The results of this study was published in the journal Nature. Dick and colleagues describe their work in which they used a stem cell marker, called CD133 in colon cancer. CD133 had earlier been tried in prostate and brain cancers.

Only a small number of colon cancer cells about one in 250 was found to be rich in CD133.

Dick and his team of researchers discovered that when human colon cancer cells high in CD133 were injected into mice, the tumors were formed at a faster rate and when cells with small amounts of CD133 were given they hardly grew.

A separate paper also published in Nature supports this study that only a very small number of colon cancer cells are responsible for tumor growth.
PRI
'"/>




Page: 1

Related medicine news :

1. Cancers of Colon & Rectum linked to Cigarette Smoking
2. Need for Colon cancer screening
3. Beer guards against Colon Cancer
4. Important substance in curry conciliate Inflamed Colon
5. Colon cancer linked with common virus
6. Colon cancer risk linked to genes causing Hemochromatosis
7. Death Risk Higher in Obese Women with Colon Cancer
8. Inflammation Linked to Colon Cancer
9. Aspirin Found To Reduce The Risk Of Colon Cancer
10. Blood Marker Found To Predict Colon Cancer
11. Estrogen Found To Protect the Colon Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... BROOKLINE, MA (PRWEB) , ... April 28, 2016 , ... ... his revolutionary work in the emerging field of biomechatronics, technology that marries human physiology ... the MIT Media Lab. He is also the Founder of BionX , a ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Management solutions, announces today the availability of its latest software release, NetZoomDC ... capacity management and optimization, providing new analytical capabilities that assess complex capacity ...
(Date:4/28/2016)... ... 28, 2016 , ... One way to ignore solid evidence is to dismiss ... we toss the baby out with the bathwater when we ignore all studies because ... studies and otherwise making better use of education policy research. , “When readers heed ...
(Date:4/28/2016)... ... April 28, 2016 , ... USA Medical Card reminds us that May is National ... stroke is the fourth leading cause of death in the United States; someone has one ... quarter of them in individuals under 65 years old. A stroke is when blood ...
(Date:4/28/2016)... ... April 28, 2016 , ... Anzu®, ... announced a new Residency Education & Collaboration Platform for hospitals and medical ... and a host of collaboration tools designed to improve patient outcomes through ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: